Safety and efficacy of moderately hypofractionated radiotherapy after radical prostatectomy: A phase II trial
- DOI
- 10.1016/j.radonc.2026.111549
- Published
- 2026-07
- Container
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.radonc.2026.111549,
title = {Safety and efficacy of moderately hypofractionated radiotherapy after radical prostatectomy: A phase II trial},
author = {Subaru Sawayanagi and Hideomi Yamashita and Taketo Kawai and Yusuke Sato and Atsuto Katano and Haruki Kume},
year = {2026},
journal = {Radiotherapy and Oncology},
doi = {10.1016/j.radonc.2026.111549},
url = {https://doi.org/10.1016/j.radonc.2026.111549}
}RIS
TY - JOUR TI - Safety and efficacy of moderately hypofractionated radiotherapy after radical prostatectomy: A phase II trial AU - Subaru Sawayanagi AU - Hideomi Yamashita AU - Taketo Kawai AU - Yusuke Sato AU - Atsuto Katano AU - Haruki Kume PY - 2026 JO - Radiotherapy and Oncology DO - 10.1016/j.radonc.2026.111549 UR - https://doi.org/10.1016/j.radonc.2026.111549 ER -
APA
Sawayanagi, S., Yamashita, H., Kawai, T., Sato, Y., Katano, A., & Kume, H. (2026). Safety and efficacy of moderately hypofractionated radiotherapy after radical prostatectomy: A phase II trial. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2026.111549
Source records
- crossref · retrieved 2026-09-25T17:27:28.662Z